{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:45:21Z","timestamp":1793259921814,"version":"4.5.0"},"reference-count":280,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2019R1I1A2A01050001"],"award-info":[{"award-number":["2019R1I1A2A01050001"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biopha.2023.115035","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T15:11:05Z","timestamp":1687619465000},"page":"115035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Therapeutic strategy for oncovirus-mediated oral cancer: A comprehensive review"],"prefix":"10.1016","volume":"165","author":[{"given":"Rekha","family":"Thiruvengadam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115035_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"vol. 149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib2","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"vol. 71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2023.115035_bib3","doi-asserted-by":"crossref","unstructured":"R. Siegel, D. Naishadham, A. Jemal, Cancer statistics, 2013, CA Cancer J. Clin. vol. 63 (2013) 11\u201330. doi: 10.3322\/caac.21166.","DOI":"10.3322\/caac.21166"},{"key":"10.1016\/j.biopha.2023.115035_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12957-020-02057-6","article-title":"Regional metastasis to anatomies beyond traditional neck dissection boundaries: a multi-institutional analysis focused on unconventional metastases in oral cancer patients","volume":"vol. 18","author":"Gao","year":"2020","journal-title":"World J. Surg. Onc"},{"key":"10.1016\/j.biopha.2023.115035_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.micinf.2014.02.009","article-title":"Viruses and oral cancer","volume":"vol. 16","author":"Sand","year":"2014","journal-title":"Is. there a Link. ? Microbes Infect."},{"key":"10.1016\/j.biopha.2023.115035_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4103\/0973-1482.119311","article-title":"The role of mast cells and angiogenesis in well-differentiated oral squamous cell carcinoma","volume":"vol. 9","author":"Tahir","year":"2013","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.biopha.2023.115035_bib7","doi-asserted-by":"crossref","unstructured":"P.H. Montero, S.G. Patel, Cancer of the oral cavity, Surg. Oncol. Clin. N. Am. vol. 24 (2015) 491\u2013508. doi: 10.1016\/j.soc.2015.03.006.","DOI":"10.1016\/j.soc.2015.03.006"},{"key":"10.1016\/j.biopha.2023.115035_bib8","doi-asserted-by":"crossref","unstructured":"S. D'souza, V.Addepalli, Preventive measures in oral cancer: An overview, Biomed. Pharmacother. vol. 107 (2018) 72\u201380. doi: 10.1016\/j.biopha.2018.07.114.","DOI":"10.1016\/j.biopha.2018.07.114"},{"key":"10.1016\/j.biopha.2023.115035_bib9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","article-title":"Incidence trends for human papillomavirus\u2013related and \u2013unrelated oral squamous cell carcinomas in the United States","volume":"vol. 26","author":"Chaturvedi","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib10","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.3390\/nu5072564","article-title":"Chemopreventive potential of flavonoids in oral squamous cell carcinoma in human studies","volume":"vol. 5","author":"Iriti","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2023.115035_bib11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2133.2012.10821.x","article-title":"Interventions for treating oral lichen planus: a systematic review","volume":"vol. 166","author":"Lodi","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2023.115035_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5125\/jkaoms.2013.39.5.207","article-title":"The impact factors on 5-year survival rate in patients operated with oral cancer","volume":"vol. 39","author":"Geum","year":"2013","journal-title":"J. Korean Assoc. Oral. Maxillofac. Surg."},{"key":"10.1016\/j.biopha.2023.115035_bib13","doi-asserted-by":"crossref","unstructured":"R. Sankaranarayanan, K. Ramadas, H. Amarasinghe, S. Subramanian, N. Johnson, Oral cancer: Prevention, early detection, and treatment, in: H. Gelband, P. Jha, R. Sankaranarayanan, S. Horton (Eds.), Cancer: Disease Control Priorities, The International Bank for Reconstruction and Development\/The World Bank, Third Ed., Washington (DC), 2015, pp. 85\u201399. doi: 10.1596\/978\u20131-4648\u20130349-9_ch5.","DOI":"10.1596\/978-1-4648-0349-9_ch5"},{"key":"10.1016\/j.biopha.2023.115035_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5005\/jp-journals-10063-0087","article-title":"Oral cancer prevention strategies: a great deal remains to be done","volume":"vol. 13","author":"Neetha","year":"2021","journal-title":"CODS J. Dent."},{"key":"10.1016\/j.biopha.2023.115035_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000092968","article-title":"Relevant oncogenic viruses in veterinary medicine: original pathogens and animal models for human disease","volume":"vol. 13","author":"Truyen","year":"2006","journal-title":"Contrib. Microbiol."},{"key":"10.1016\/j.biopha.2023.115035_bib16","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/0042-6822(56)90064-2","article-title":"Discrete foci of altered chicken embryo cells associated with Rous sarcoma virus in tissue culture","volume":"vol. 2","author":"Groupe","year":"1956","journal-title":"Virology"},{"key":"10.1016\/j.biopha.2023.115035_bib17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0042-6822(58)90114-4","article-title":"Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture","volume":"vol. 6","author":"Temin","year":"1958","journal-title":"Virology"},{"key":"10.1016\/j.biopha.2023.115035_bib18","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.4317\/medoral.20630","article-title":"Nested PCR for detection of HSV-1 in oral mucosa","volume":"vol. 20","author":"Jalouli","year":"2015","journal-title":"Med. Oral. Patol. Oral. Cirugia Bucal"},{"key":"10.1016\/j.biopha.2023.115035_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.virol.2008.09.034","article-title":"The common mechanisms of transformation by the small DNA tumor viruses: the inactivation of tumor suppressor gene products: p53","volume":"vol. 384","author":"Levine","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.biopha.2023.115035_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0714.2004.00192.x","article-title":"Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma","volume":"vol. 33","author":"Iamaroon","year":"2004","journal-title":"J. Oral. Pathol. Med"},{"key":"10.1016\/j.biopha.2023.115035_bib21","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1002\/jcb.26717","article-title":"Searching for human oncoviruses: histories, challenges, and opportunities","volume":"vol. 119","author":"Cao","year":"2018","journal-title":"J. Cell. Biochem"},{"key":"10.1016\/j.biopha.2023.115035_bib22","series-title":"Squamous cell carcinoma hallmark and treatment modalities, IntechOpen","first-page":"1","article-title":"Molecular pathogenesis of oral squamous cell carcinoma","author":"Jain","year":"2019"},{"key":"10.1016\/j.biopha.2023.115035_bib23","first-page":"8459","article-title":"Serologic evidence of herpes simplex virus 1 infection and oropharyngeal cancer risk","volume":"vol. 61","author":"Starr","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2023.115035_bib24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM198603133141105","article-title":"Infections with herpes simplex viruses","volume":"vol. 314","author":"Corey","year":"1986","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2023.115035_bib25","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2741\/taylor","article-title":"Herpes simplex virus","volume":"vol. 7","author":"Taylor","year":"2002","journal-title":"Front. Biosci."},{"key":"10.1016\/j.biopha.2023.115035_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coviro.2016.08.007","article-title":"Retargeting of herpes simplex virus (HSV) vectors","volume":"vol. 21","author":"Goins","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/v8030063","article-title":"Retargeting strategies for oncolytic herpes simplex viruses","volume":"vol. 8","author":"Campadelli-Fiume","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2023.115035_bib28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.oraloncology.2005.08.003","article-title":"Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors","volume":"vol. 42","author":"Parker","year":"2006","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib29","first-page":"167","volume":"vol. 38","author":"Djuric","year":"2009","journal-title":"Preval. Oral. herpes Simple Virus React. Cancer Patient-.: a Comp. Differ. Tech. Viral Detect., J. Oral. Pathol. Med"},{"key":"10.1016\/j.biopha.2023.115035_bib30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.coms.2014.01.004","article-title":"Chemotherapy for oral and maxillofacial tumors: an update","volume":"vol. 26","author":"Eid","year":"2014","journal-title":"Oral. Maxillofac. Surg. Clin. North Am."},{"key":"10.1016\/j.biopha.2023.115035_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.oraloncology.2010.03.003","article-title":"Infectious and dietary risk factors of oral cancer","volume":"vol. 46","author":"Meurman","year":"2010","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib32","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3109\/00016481003782041","article-title":"Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India","volume":"vol. 130","author":"Jalouli","year":"2010","journal-title":"Acta Oto-Laryngol."},{"key":"10.1016\/j.biopha.2023.115035_bib33","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1128\/JVI.02726-07","article-title":"Arrangement of L2 within the papillomavirus capsid","volume":"vol. 82","author":"Buck","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib34","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/modpathol.3880113","article-title":"High risk\" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa","volume":"vol. 13","author":"Bouda","year":"2000","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.biopha.2023.115035_bib35","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1365-2133.2004.05847.x","article-title":"Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin","volume":"vol. 150","author":"Harwood","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2023.115035_bib36","first-page":"57","article-title":"The role of human papillomavirus in nongenital cancers","volume":"vol. 63","author":"Zandberg","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2023.115035_bib37","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S1470-2045(14)70471-1","article-title":"E6\/E7 mRNA, and p16 INK4a detection in head and neck cancers: a systematic review and meta-analysis","volume":"vol. 15","author":"Ndiaye","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.virol.2003.11.004","article-title":"Kinetics of in vitro adsorption and entry of papillomavirus virions","volume":"vol. 319","author":"Culp","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.biopha.2023.115035_bib39","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s00018-009-8631-7","article-title":"The regulation of cell proliferation by the papillomavirus early proteins","volume":"vol. 66","author":"Hamid","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2023.115035_bib40","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s12105-012-0367-2","article-title":"Biology of human papillomavirus infections in head and neck carcinogenesis","volume":"vol. 6","author":"Rautava","year":"2012","journal-title":"Head. Neck Pathol."},{"key":"10.1016\/j.biopha.2023.115035_bib41","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.3390\/v6104047","article-title":"Human viruses and cancer","volume":"vol. 6","author":"Morales-S\u00e1nchez","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2023.115035_bib42","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1128\/JCM.37.4.1030-1034.1999","article-title":"Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type","volume":"vol. 37","author":"Swan","year":"1999","journal-title":"J. Clin. Microbiol"},{"key":"10.1016\/j.biopha.2023.115035_bib43","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1128\/JVI.02093-10","article-title":"Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers","volume":"vol. 85","author":"Lace","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib44","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/jamaoto.2013.5460","article-title":"High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods","volume":"vol. 139","author":"Walline","year":"2013","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.biopha.2023.115035_bib45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"vol. 363","author":"Ang","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2023.115035_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1054\/ijom.2002.0443","article-title":"Human papillomavirus type 16 and 18 DNA in oral squamous cell carcinoma and normal mucosa","volume":"vol. 33","author":"Zhang","year":"2004","journal-title":"Int. J. Oral. Maxillaofac. Surg."},{"key":"10.1016\/j.biopha.2023.115035_bib47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.currproblcancer.2017.02.006","article-title":"Human papillomavirus and oral squamous cell carcinoma: a review of HPV-positive oral squamous cell carcinoma and possible strategies for future","volume":"vol. 41","author":"Jiang","year":"2017","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1631\/jzus.B1200189","article-title":"Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells","volume":"vol. 14","author":"Qin","year":"2013","journal-title":"J. Zhejiang Univ. -Sci. B"},{"key":"10.1016\/j.biopha.2023.115035_bib49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/odi.12656","article-title":"Epstein-Barr virus in the pathogenesis of oral cancers","volume":"vol. 24","author":"Guidry","year":"2018","journal-title":"Oral. Dis."},{"key":"10.1016\/j.biopha.2023.115035_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary epstein barr virus infections","volume":"vol. 24","author":"Odumade","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.biopha.2023.115035_bib51","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/cancers12061479","article-title":"Oncogenic properties of the EBV ZEBRA Protein","volume":"vol. 12","author":"Germini","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2023.115035_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/rmv.441","article-title":"Latent and lytic Epstein-Barr virus replication strategies","volume":"vol. 15","author":"Tsurumi","year":"2005","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib53","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11899-016-0355-9","article-title":"Extranodal NK\/T cell lymphoma, nasal type (ENKTL-NT): an update on epidemiology, clinical presentation, and natural history in North American and European cases","volume":"vol. 11","author":"Haverkos","year":"2016","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.biopha.2023.115035_bib54","article-title":"Detection of EBV infection and gene expression in oral cancer from patients in Taiwan by microarray analysis","volume":"vol. 2009","author":"Yen","year":"2009","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.biopha.2023.115035_bib55","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/v14040801","article-title":"Potential role of Epstein-Barr virus in oral potentially malignant disorders and oral squamous cell carcinoma: a scoping review","volume":"vol. 14","author":"Rahman","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2023.115035_bib56","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12903-021-01867-8","article-title":"Detection of Epstein-Barr virus encoded small RNA genes in oral squamous cell carcinoma and non-cancerous oral cavity samples","volume":"vol. 21","author":"Zebardast","year":"2021","journal-title":"BMC Oral. Health"},{"key":"10.1016\/j.biopha.2023.115035_bib57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-pathmechdis-012418-013023","article-title":"Epstein - Barr virus and cancer","volume":"vol. 14","author":"Farrell","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.biopha.2023.115035_bib58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1615\/CritRevOncog.2020033071","article-title":"Role of Epstein - Barr virus and human papillomavirus coinfection in oral and anogenital carcinogenesis: potential tumorigenic pathways","volume":"vol. 24","author":"de Lima","year":"2019","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.biopha.2023.115035_bib59","doi-asserted-by":"crossref","unstructured":"K.V. Chaitanya, Structure and organization of virus genomes, in: K.V. Chaitanya (Eds.), Genome and Genomics: From Archaea to Eukaryotes, Springer, Singapore, 2019, pp. 1\u201330. doi: 10.1007\/978\u2013981-15\u20130702-1_1.","DOI":"10.1007\/978-981-15-0702-1_1"},{"key":"10.1016\/j.biopha.2023.115035_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.coviro.2013.03.004","article-title":"Epigenetic regulation of EBV and KSHV latency","volume":"vol. 3","author":"Chen","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib61","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.3390\/ijms19092560","article-title":"The HSP90 family: structure, regulation, function, and implications in health and disease","volume":"vol. 19","author":"Hoter","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115035_bib62","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.3390\/v6104024","article-title":"Interaction of KSHV with host cell surface receptors and cell entry","volume":"vol. 6","author":"Veettil","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2023.115035_bib63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fmicb.2012.00006","article-title":"Kaposi\u2019s sarcoma associated herpesvirus entry into target cells","volume":"vol. 3","author":"Chakraborty","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2023.115035_bib64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/v8110305","article-title":"KSHV Entry and Trafficking in Target Cells-Hijacking of Cell Signal Pathways, Actin and Membrane Dynamics","volume":"vol. 8","author":"Kumar","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2023.115035_bib65","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1128\/JVI.01334-09","article-title":"Early EVENTS in Kaposi\u2019s sarcoma-associated herpesvirus infection of target cells","volume":"vol. 84","author":"Chandran","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib66","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.3390\/v6124961","article-title":"KSHV LANA\u2014the master regulator of KSHV latency","volume":"vol. 6","author":"Uppal","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2023.115035_bib67","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fmicb.2012.00030","article-title":"Promoter specification and viral reactivation","volume":"vol. 3","author":"Guito","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2023.115035_bib68","doi-asserted-by":"crossref","unstructured":"N.K. Conrad, New Insights into the Expression and Functions of the Kaposi\u2019s Sarcoma-Associated Herpesvirus Long Noncoding PAN RNA, Virus Res. vol. 12 (2015) 53\u201363. doi: 10.1016\/j.virus res.2015.06.012.","DOI":"10.1016\/j.virusres.2015.06.012"},{"key":"10.1016\/j.biopha.2023.115035_bib69","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fmicb.2017.00613","article-title":"Reactivation and lytic replication of Kaposi\u2019s sarcoma-associated herpesvirus: an update","volume":"vol. 8","author":"Aneja","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2023.115035_bib70","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-4632.2012.05758.x","article-title":"Oral Kaposi's sarcoma: a review and update","volume":"vol. 52","author":"Fatahzadeh","year":"2013","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.biopha.2023.115035_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003813","article-title":"Biphasic euchromatin-to- heterochromatin transition on the KSHV genome following de novo infection","volume":"vol. 9","author":"Toth","year":"2013","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.biopha.2023.115035_bib72","first-page":"1","article-title":"Oral Kaposi\u2019s sarcoma: a case report and literature review on treatment management","volume":"vol. 6","author":"Thieringer","year":"2021","journal-title":"Craniomaxillofac. Trauma Reconstr."},{"key":"10.1016\/j.biopha.2023.115035_bib73","first-page":"1331","article-title":"Kaposi sarcoma-associated herpesvirus and staphylococcus aureus coinfection in oral cavities of HIV-positive patients: a unique niche for oncogenic virus lytic reactivation","volume":"vol. 221","author":"Dai","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2023.115035_bib74","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(00)03503-0","article-title":"Outlook in oral and cutaneous Kaposi\u2019s sarcoma","volume":"vol. 356","author":"Rohrmus","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.115035_bib75","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.oraloncology.2015.09.006","article-title":"Clinical implications of epigenetic regulation in oral cancer","volume":"vol. 51","author":"D\u2019Souza","year":"2015","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib76","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.oooo.2018.03.012","article-title":"Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: current knowledge and future implications","volume":"vol. 125","author":"Nikitakis","year":"2018","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radio."},{"key":"10.1016\/j.biopha.2023.115035_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205518","article-title":"The role of NF-\u03baB and miRNA in oral cancer and cancer stem cells with or without HPV16 infection","volume":"vol. 13","author":"Bano","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115035_bib78","doi-asserted-by":"crossref","first-page":"35184","DOI":"10.18632\/oncotarget.17059","article-title":"Apoptosis-related microRNA-145-5p enhances the effects of pheophorbide a-based photodynamic therapy in oral cancer","volume":"vol. 8","author":"Moon","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2023.115035_bib79","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3892\/or.2017.5899","article-title":"MicroRNA-218 promotes cisplatin resistance in oral cancer via the PPP2R5A\/Wnt signaling pathway","volume":"vol. 38","author":"Zhuang","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2023.115035_bib80","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41598-022-05399-1","article-title":"Prognostic impact of miR-34b\/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas","volume":"vol. 12","author":"Supic","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115035_bib81","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/s41467-022-28479-2","article-title":"EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1","volume":"vol. 13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115035_bib82","first-page":"16205","article-title":"EBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1","volume":"vol. 34","author":"Wu","year":"2020","journal-title":"Fed. Am. Sci. Exp. Biol."},{"key":"10.1016\/j.biopha.2023.115035_bib83","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1128\/JVI.02830-15","article-title":"Secreted oral epithelial cell membrane vesicles induce Epstein - barr virus reactivation in latently infected B Cells","volume":"vol. 90","author":"Lin","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008114","article-title":"Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA","volume":"vol. 16","author":"Gruffaz","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2023.115035_bib85","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/2045-3701-1-41","article-title":"Roles of TGF\u03b2 signaling Smads in squamous cell carcinoma","volume":"vol. 1","author":"Han","year":"2011","journal-title":"Cell Biosci."},{"key":"10.1016\/j.biopha.2023.115035_bib86","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.3390\/ijms20112767","article-title":"TGF-\u03b2-mediated epithelial-mesenchymal transition and cancer metastasis","volume":"vol. 20","author":"Hao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115035_bib87","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/07853890600919911","article-title":"Mutations of TGF beta signaling molecules in human disease","volume":"vol. 38","author":"Harradine","year":"2006","journal-title":"Ann. Med."},{"key":"10.1016\/j.biopha.2023.115035_bib88","first-page":"1327","article-title":"genetic variant at the miRNA187 binding site significantly modifies risk of HPV16\u2013associated oropharyngeal cancer, Int. J. Cancer","volume":"vol. 143","author":"Tao","year":"2018"},{"key":"10.1016\/j.biopha.2023.115035_bib89","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management","volume":"vol. 19","author":"Lechner","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib90","first-page":"196","article-title":"MEM16A","volume":"vol. 41","author":"Okuyama","year":"2022","journal-title":"a Potential Treat. Target Head. neck Cancer, J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2023.115035_bib91","first-page":"45","article-title":"Salivary and serum IL-10, TNF-\u03b1, TGF-\u03b2, VEGF levels in oropharyngeal squamous cell carcinoma and correlation with HPV and EBV infections, Infect","volume":"vol. 11","author":"Polz-Dacewicz","year":"2016","journal-title":"Agent Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib92","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/ijc.25173","article-title":"Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization","volume":"vol. 127","author":"Tsang","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib93","doi-asserted-by":"crossref","unstructured":"J.K. Tay, C. Zhu, J.H. Shin, S.X. Zhu, S. Varma, J.W. Foley, S. Vennam, Y.L. Yip, C.K. Goh, D.Y. Wang, K.S. Loh, S.W. Tsao, Q.T. Le, J.B. Sunwoo, R.B. West, The microdissected gene expression landscape of nasopharyngeal cancer reveals vulnerabilities in FGF and noncanonical NF-\u03baB signaling, Sci. Adv. vol. 8 (2022) eabh2445. doi: 10.1126\/sciadv. abh2445.","DOI":"10.1126\/sciadv.abh2445"},{"key":"10.1016\/j.biopha.2023.115035_bib94","series-title":"Prevention, detection and management of oral cancer","first-page":"69","article-title":"Management strategies for oral cancer subsites","author":"Gupta","year":"2019"},{"key":"10.1016\/j.biopha.2023.115035_bib95","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1182\/blood-2007-09-110544","article-title":"inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor","volume":"vol. 111","author":"Di Bartolo","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2023.115035_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005255","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) induces the oncogenic miR-17-92 cluster and down-regulates TGF-\u03b2 signaling","volume":"vol. 11","author":"Choi","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2023.115035_bib97","first-page":"1951","article-title":"Chemotherapeutic alteration of VEGF, PDGF and PDGFR\u03b1\/\u03b2 expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro","volume":"vol. 33","author":"Aderhold","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.biopha.2023.115035_bib98","doi-asserted-by":"crossref","unstructured":"Q. Du, Z. Gu, I. Leneva, H. Jiang, R. Li, L. Deng, Z. YangThe antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis, Int. Immunopharmacol. vol. 68 (2019) 58\u201367. doi: 10.1016\/j.intimp.2018.09.043.","DOI":"10.1016\/j.intimp.2018.09.043"},{"key":"10.1016\/j.biopha.2023.115035_bib99","article-title":"Transcriptional changes after herpes simplex virus type 1 infection in human trabecular meshwork cells","volume":"vol. 14","author":"Choi","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115035_bib100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12974-019-1647-5","article-title":"HSV-1 triggers paracrine fibroblast growth factor response from cortical brain cells via immediate-early protein ICP0","volume":"vol. 16","author":"Hensel","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2023.115035_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027800","article-title":"Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases","volume":"vol. 6","author":"Lasithiotaki","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115035_bib102","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.2162560","article-title":"Fibroblast growth factor receptor is a portal of cellular entry for herpes simplex virus type 1","volume":"vol. 248","author":"Kaner","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.biopha.2023.115035_bib103","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0030-4220(89)90141-2","article-title":"Herpes simplex virus enhances the 7,12-dimethylbenz[a]anthracene (DMBA)-induced carcinogenesis and amplification and overexpression of c-erb-B-1 proto-oncogene in hamster buccal pouch epithelium","volume":"vol. 68","author":"Oh","year":"1989","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol."},{"key":"10.1016\/j.biopha.2023.115035_bib104","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3390\/cancers12071904","article-title":"Human papillomavirus 16 E7 promotes EGFR\/PI3K\/AKT1\/NRF2 signaling pathway contributing to PIR\/NF-\u03baB activation in oral cancer cells","volume":"vol. 12","author":"Carrillo-Beltr\u00e1n","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2023.115035_bib105","first-page":"e01782","article-title":"Human immunodeficiency virus-associated exosomes promote Kaposi's sarcoma-associated herpesvirus infection via the epidermal growth factor","volume":"vol. 94","author":"Chen","year":"2020","journal-title":"Recept. J. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib106","first-page":"1379","article-title":"Mitogen-activated protein kinase signaling pathway in oral cancer","volume":"vol. 15","author":"Peng","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2023.115035_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.10.033","article-title":"MAP kinase signaling cascades and transcriptional regulation","volume":"vol. 513","author":"Yang","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2023.115035_bib108","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.3390\/ijms22095012","article-title":"Platyphyllenone exerts anti-metastatic effects on human oral cancer cells by modulating cathepsin L Expression, MAPK pathway and epithelial-mesenchymal transition","volume":"vol. 22","author":"Kumar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115035_bib109","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.2217\/fon-2019-0338","article-title":"Cigarette smoking promotes cancer-related transformation of oral epithelial cells through activation of Wnt and MAPK pathway","volume":"vol. 15","author":"Sarkar","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99327","article-title":"The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer","volume":"vol. 3","author":"Harbison","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2023.115035_bib111","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/cancers11040584","article-title":"Differential activation of ERK signaling in HPV-related oropharyngeal squamous cell carcinoma","volume":"vol. 11","author":"Rong","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2023.115035_bib112","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ijc.10455","article-title":"Transcriptional profiling of a human papillomavirus 33-positive squamous epithelial cell line which acquired a selective growth advantage after viral integration","volume":"vol. 100","author":"Ruutu","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.618931","article-title":"Current trends of targeted drug delivery for oral cancer therapy","volume":"vol. 8","author":"Zhang","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2023.115035_bib114","first-page":"43","article-title":"Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines","volume":"vol. 13","author":"Chaiwongkot","year":"2020","journal-title":"Biomed. Res. Int"},{"key":"10.1016\/j.biopha.2023.115035_bib115","doi-asserted-by":"crossref","first-page":"19533","DOI":"10.1038\/srep19533","article-title":"The Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A\/TGF\u03b2 and \u03b21 integrin signalling","volume":"vol. 6","author":"Morris","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115035_bib116","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10637-012-9896-5","article-title":"Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines","volume":"vol. 31","author":"Ma","year":"2013","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.biopha.2023.115035_bib117","article-title":"Lipoteichoic acid (LTA) and lipopolysaccharides (LPS) from periodontal pathogenic bacteria facilitate oncogenic herpesvirus infection within primary oral cells","volume":"vol. 9","author":"Dai","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115035_bib118","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ijc.26428","article-title":"KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction","volume":"vol. 131","author":"Dai","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib119","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1158\/0008-5472.CAN-15-0199","article-title":"Notch1 activation or loss promotes HPV-induced oral tumorigenesis","volume":"vol. 75","author":"Zhong","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2023.115035_bib120","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1038\/onc.2011.589","article-title":"Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling","volume":"vol. 31","author":"Brimer","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2023.115035_bib121","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/carcin\/bgu069","article-title":"Epstein-Barr virus latent membrane protein-2A alters mitochondrial dynamics promoting cellular migration mediated by Notch signaling pathway","volume":"vol. 35","author":"Pal","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2023.115035_bib122","doi-asserted-by":"crossref","first-page":"e01978","DOI":"10.1128\/JVI.01978-18","article-title":"Genome-Wide Identification of direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation","volume":"vol. 93","author":"Papp","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib123","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00430-020-00697-9","article-title":"Differential Wnt-\u03b2- catenin pathway activation in HPV positive and negative oral epithelium is transmitted during head and neck tumorigenesis: clinical implications","volume":"vol. 210","author":"Chakraborty","year":"2021","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.biopha.2023.115035_bib124","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.18632\/oncotarget.23824","article-title":"Epstein-Barr virus stably confers an invasive phenotype to epithelial cells through reprogramming of the WNT pathway","volume":"vol. 9","author":"Birdwell","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2023.115035_bib125","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3892\/ijo.2014.2342","article-title":"Oncogenic effects of WNT5A in Epstein-Barr virus associated nasopharyngeal carcinoma","volume":"vol. 44","author":"Yap","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib126","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3332\/ecancer.2015.525","article-title":"Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer","volume":"vol. 9","author":"Mishra","year":"2015","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.biopha.2023.115035_bib127","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.humpath.2021.08.004","article-title":"Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus-associated nasopharyngeal carcinoma","volume":"vol. 117","author":"Viswanathan","year":"2021","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.biopha.2023.115035_bib128","doi-asserted-by":"crossref","first-page":"1249783","DOI":"10.1126\/science.1249783","article-title":"Mechanism of activation of protein kinase JAK2 by the growth hormone receptor","volume":"vol. 344","author":"Brooks","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.biopha.2023.115035_bib129","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41417-018-0074-6","article-title":"JAK\/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models","volume":"vol. 26","author":"Patel","year":"2019","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biopha.2023.115035_bib130","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/iub.2012","article-title":"LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma","volume":"vol. 71","author":"Tan","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopha.2023.115035_bib131","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12885-016-2265-6","article-title":"Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK\/STAT signaling pathway suppression and apoptosis induction","volume":"vol. 16","author":"Huang","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib132","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2147\/DDDT.S284213","article-title":"Flavopereirine suppresses the progression of human oral cancer by inhibiting the JAK-STAT signaling pathway via targeting LASP1","volume":"vol. 15","author":"Xu","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.biopha.2023.115035_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154776","article-title":"IL-22 suppresses HSV-2 replication in human cervical epithelial cells","volume":"vol. 123","author":"Xu","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2023.115035_bib134","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1128\/JVI.75.9.4283-4296.2001","article-title":"Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes","volume":"vol. 75","author":"Nees","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib135","doi-asserted-by":"crossref","first-page":"e00828","DOI":"10.1128\/mSphere.00828-19","article-title":"Human papillomavirus 16 E6 and E7 synergistically repress innate immune gene transcription","volume":"vol. 5","author":"James","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.biopha.2023.115035_bib136","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12032-016-0800-6","article-title":"Effect of human papillomavirus 16 oncoproteins on oncostatin M upregulation in oral squamous cell carcinoma","volume":"vol. 33","author":"Chuerduangphui","year":"2016","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib137","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/ijc.29558","article-title":"NF-\u03baB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma","volume":"vol. 137","author":"Gaykalova","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007835","article-title":"Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1\u2014NF\u03baB\u2014IL-6 signalling axis","volume":"vol. 15","author":"Morgan","year":"2019","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.biopha.2023.115035_bib139","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1016\/j.ejca.2013.07.140","article-title":"Activation of interleukin 6\/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment","volume":"vol. 49","author":"Ren","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006975","article-title":"STAT3 activation by E6 is essential for the differentiation dependent HPV18 life cycle","volume":"vol. 14","author":"Morgan","year":"2018","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.biopha.2023.115035_bib141","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00007890-200208150-00017","article-title":"Constitutive activation of Jak\/STAT proteins in Epstein-Barr virus B cell lines from patients with posttransplant lymphoproliferative disorder","volume":"vol. 74","author":"Nepomuceno","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.biopha.2023.115035_bib142","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1111\/j.1600-6143.2009.02781.x","article-title":"Activation of the JAK\/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma","volume":"vol. 9","author":"Vaysberg","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.biopha.2023.115035_bib143","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1128\/JVI.79.8.4936-4943.2005","article-title":"Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells","volume":"vol. 79","author":"Najjar","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib144","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12903-019-0832-3","article-title":"Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma","volume":"vol. 19","author":"Rahman","year":"2019","journal-title":"BMC Oral. Health"},{"key":"10.1016\/j.biopha.2023.115035_bib145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fonc.2018.00111","article-title":"Epstein - Barr virus and human papillomaviruses interactions and their roles in the initiation of epithelial-mesenchymal transition and cancer progression","volume":"vol. 8","author":"Cyprian","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib146","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12935-018-0605-0","article-title":"Clinicopathologic and prognostic significance of VEGF, JAK2 and STAT3 in patients with nasopharyngeal carcinoma","volume":"vol. 18","author":"Cheng","year":"2018","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.biopha.2023.115035_bib147","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/10428194.2018.1512709","article-title":"The JAK inhibitor antcin H exhibits direct anticancer activity while enhancing chemotherapy against LMP1-expressed lymphoma","volume":"vol. 60","author":"Chen","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.biopha.2023.115035_bib148","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12935-021-01793-3","article-title":"Signaling pathways of EBV-induced oncogenesis","volume":"vol. 21","author":"Luo","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.biopha.2023.115035_bib149","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1128\/JVI.02024-06","article-title":"Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK\/STAT signaling","volume":"vol. 81","author":"Zeng","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib150","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1128\/JVI.01525-15","article-title":"Constitutive activation of interleukin-13\/STAT6 contributes to Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma cell proliferation and survival","volume":"vol. 89","author":"Wang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib151","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1128\/JVI.02516-08","article-title":"A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction","volume":"vol. 83","author":"Bisson","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib152","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3389\/fimmu.2012.00401","article-title":"AKTivation of PI3K\/AKT\/mTOR signaling pathway by KSHV","volume":"vol. 3","author":"Bhatt","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115035_bib154","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1517\/14728222.2011.541440","article-title":"EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy","volume":"vol. 15","author":"Freudlsperger","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2023.115035_bib155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"vol. 11","author":"Leemans","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib156","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.3390\/ijms21093285","article-title":"Targeting AKT\/mTOR in oral cancer: mechanisms and advances in clinical trials","volume":"vol. 21","author":"Harsha","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115035_bib157","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/molecules24081584","article-title":"Brassinin represses invasive potential of lung carcinoma cells through deactivation of PI3K\/Akt\/mTOR signaling cascade","volume":"vol. 24","author":"Yang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.115035_bib158","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/biom9070253","article-title":"Isoform-specific role of Akt in oral squamous cell carcinoma","volume":"vol. 9","author":"Roy","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2023.115035_bib159","first-page":"292","article-title":"Mecambridine induces potent cytotoxic effects, autophagic cell death and modulation of the mTOR\/PI3K\/Akt signaling pathway in HSC-3 oral squamous cell carcinoma cells","volume":"vol. 15","author":"Lin","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2023.115035_bib160","doi-asserted-by":"crossref","first-page":"5228713","DOI":"10.1155\/2021\/5228713","article-title":"Anlotinib suppresses oral squamous cell carcinoma growth and metastasis by targeting the RAS protein to inhibit the PI3K\/Akt signalling pathway","volume":"vol. 2021","author":"Lu","year":"2021","journal-title":"Anal. Cell. Pathol."},{"key":"10.1016\/j.biopha.2023.115035_bib161","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/v14071372","article-title":"Targeted therapy of HPV positive and negative tonsillar squamous cell carcinoma cell lines reveals synergy between CDK4\/6, PI3K and sometimes FGFR inhibitors, but rarely between PARP and WEE1 Inhibitors","volume":"vol. 14","author":"Kostopoulou","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2023.115035_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.105939","article-title":"Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma","volume":"vol. 131","author":"Yang","year":"2022","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib163","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1158\/0008-5472.CAN-17-1672","article-title":"Cross-talk signaling between HER3 and HPV16 E6 and E7 mediates resistance to PI3K inhibitors in head and neck cancer","volume":"vol. 78","author":"Brand","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2023.115035_bib164","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1158\/1078-0432.CCR-16-2203","article-title":"Human papillomavirus regulates HER3 expression in head and neck cancer: implications for targeted HER3 Therapy in HPV+ Patients","volume":"vol. 23","author":"Brand","year":"2017","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2023.115035_bib165","article-title":"Activation of Akt\/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma","volume":"vol. 9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115035_bib166","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1002\/cam4.2506","article-title":"LMP1-positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling","volume":"vol. 8","author":"Zhang","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.biopha.2023.115035_bib167","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1038\/onc.2015.402","article-title":"EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K\/AKT pathway by a positive feedback loop","volume":"vol. 35","author":"Yang","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2023.115035_bib168","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1515\/med-2017-0025","article-title":"Role of Epstein - Barr virus in the development of nasopharyngeal carcinoma","volume":"vol. 12","author":"Zhang","year":"2017","journal-title":"Open Med"},{"key":"10.1016\/j.biopha.2023.115035_bib169","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/cam4.1311","article-title":"Antitumor effects of duvelisib on Epstein-Barr virus-associated lymphoma cells","volume":"vol. 7","author":"Kawada","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.biopha.2023.115035_bib170","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/onc.2013.193","article-title":"Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene","volume":"vol. 33","author":"Martin","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2023.115035_bib171","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jnutbio.2016.12.011","article-title":"Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K\/AKT\/mTOR and STAT3 signaling pathways","volume":"vol. 41","author":"Granato","year":"2017","journal-title":"J. Nutr. Biochem"},{"key":"10.1016\/j.biopha.2023.115035_bib172","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ccr.2011.05.005","article-title":"PI3K\u03b3 mediates kaposi's sarcoma-associated herpesvirus vGPCR-induced sarcomagenesis","volume":"vol. 19","author":"Martin","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2023.115035_bib173","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1002\/ijc.22262","article-title":"Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high-risk human papillomavirus infection","volume":"vol. 119","author":"Mishra","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib174","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm2083","article-title":"Integrating cell-signalling pathways with NF-\u03baB and IKK function","volume":"vol. 8","author":"Perkins","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115035_bib175","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13027-022-00475-7","article-title":"Activating transcription factor 3 inhibits NF\u2011\u03baB p65 signaling pathway and mediates apoptosis and cell cycle arrest in cervical cancer cells","volume":"vol. 17","author":"Arsanjani","year":"2022","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib176","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/cam4.983","article-title":"Characterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers","volume":"vol. 6","author":"Verma","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.biopha.2023.115035_bib177","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s42770-020-00391-1","article-title":"The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16INK4a and NF-\u03baB expression in head and neck squamous cell carcinomas in Southwestern Iran","volume":"vol. 52","author":"Pakdel","year":"2021","journal-title":"Braz. J. Microbiol"},{"key":"10.1016\/j.biopha.2023.115035_bib178","first-page":"25576","article-title":"The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa","volume":"vol. 277","author":"Spitkovsky","year":"2002","journal-title":"B kinase Complex. J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115035_bib179","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jasc.2021.06.008","article-title":"p16 immunostaining in fine-needle aspirations of the head and neck: determining the optimal positivity threshold in HPV-related squamous cell cancer","volume":"vol. 10","author":"Wang","year":"2021","journal-title":"J. Am. Soc. Cytopathol."},{"key":"10.1016\/j.biopha.2023.115035_bib180","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s12885-021-08397-0","article-title":"Co-expression of low-risk HPV E6\/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage","volume":"vol. 21","author":"Uehara","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib181","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1038\/s41467-021-24348-6","article-title":"Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-\u03baB activation and immune escape","volume":"vol. 12","author":"Bruce","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115035_bib182","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1158\/0008-5472.CAN-20-4321","article-title":"Epstein-Barr virus-encoded circular RNA CircBART2.2 promotes immune escape of nasopharyngeal carcinoma by regulating PD-L1","volume":"vol. 81","author":"Ge","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2023.115035_bib183","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/sj.onc.1210817","article-title":"An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia","volume":"vol. 27","author":"Martin","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2023.115035_bib184","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2003-12-4436","article-title":"The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia","volume":"vol. 104","author":"Montaner","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2023.115035_bib185","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.3892\/or.2016.4724","article-title":"Circadian clock gene Per2 plays an important role in cell proliferation, apoptosis and cell cycle progression in human oral squamous cell carcinoma","volume":"vol. 35","author":"Wang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2023.115035_bib186","first-page":"ZE18","article-title":"Molecular classification of oral squamous cell carcinoma","volume":"vol. 10","author":"Bavle","year":"2016","journal-title":"J. Clin. Diagn. Res"},{"key":"10.1016\/j.biopha.2023.115035_bib187","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1158\/1541-7786.MCR-13-0350","article-title":"The molecular balancing act of p16(INK4a) in cancer and aging","volume":"vol. 12","author":"LaPak","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2023.115035_bib188","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/jop.12562","article-title":"p16 and p53 in HPV-positive versus HPV-negative oral squamous cell carcinoma: do pathways differ","volume":"vol. 46","author":"Singh","year":"2017","journal-title":"? J. Oral. Pathol. Med."},{"key":"10.1016\/j.biopha.2023.115035_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118236","article-title":"Metabolic regulation in HPV associated head and neck squamous cell carcinoma","volume":"vol. 258","author":"Chandel","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.115035_bib190","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1002\/hed.24604","article-title":"Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1","volume":"vol. 39","author":"Beck","year":"2017","journal-title":"Head. Neck"},{"key":"10.1016\/j.biopha.2023.115035_bib191","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1158\/1541-7786.MCR-18-0924","article-title":"Targeted therapy for EBV-associated B-cell neoplasms","volume":"vol. 17","author":"Ganguly","year":"2019","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.biopha.2023.115035_bib192","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virol.2018.12.015","article-title":"STAT3 phosphorylation affects p53\/p21 axis and KSHV lytic cycle activation","volume":"vol. 528","author":"Santarelli","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.biopha.2023.115035_bib193","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/v11010008","article-title":"Cytotoxic drugs activate kshv lytic cycle in LAtently Infected PEL cells by inducing a moderate ROS increase controlled by HSF1, NRF2 and p62\/SQSTM1","volume":"vol. 11","author":"Granato","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2023.115035_bib194","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/hed.21974","article-title":"p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency","volume":"vol. 34","author":"El-Naggar","year":"2012","journal-title":"Head. Neck"},{"key":"10.1016\/j.biopha.2023.115035_bib195","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.4317\/medoral.18213","article-title":"The role of p21Waf1\/CIP1 as a Cip\/Kip type cell-cycle regulator in oral squamous cell carcinoma (Review)","volume":"vol. 18","author":"P\u00e9rez-Say\u00e1ns","year":"2013","journal-title":"Med. Oral. Patol. Oral. Cir. Bucal"},{"key":"10.1016\/j.biopha.2023.115035_bib196","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1590\/S1678-77572008000500007","article-title":"Detection of HPV DNA and immunohistochemical expression of cell cycle proteins in oral carcinoma in a population of Brazilian patients","volume":"vol. 16","author":"Soares","year":"2008","journal-title":"J. Appl. Oral. Sci."},{"key":"10.1016\/j.biopha.2023.115035_bib197","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.acthis.2009.08.008","article-title":"Abnormal cell-cycle expression of the proteins p27, mdm2, and cathepsin B in oral squamous-cell carcinoma infected with human papillomavirus","volume":"vol. 113","author":"Mazon","year":"2011","journal-title":"Acta Histochem"},{"key":"10.1016\/j.biopha.2023.115035_bib198","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4081\/oncol.2020.472","article-title":"Apoptosis and genes involved in oral cancer - a comprehensive review","volume":"vol. 14","author":"Dwivedi","year":"2020","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.biopha.2023.115035_bib199","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2121-7-6","article-title":"Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: A cytometric study","volume":"vol. 7","author":"Fabbri","year":"2006","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.biopha.2023.115035_bib200","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-08-0144","article-title":"Bcl-2 inhibitors: Targeting mitochondrial apoptotic pathways in cancer therapy","volume":"vol. 15","author":"Kang","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2023.115035_bib201","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.455","article-title":"Bortezomib sensitises TRAIL-resistant HPV-positive head and neck cancer cells to TRAIL through a caspase-dependent, E6-independent mechanism","volume":"vol. 5","author":"Bullenkamp","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.115035_bib202","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.21873\/anticanres.14639","article-title":"Apoptosis-related proteins are altered by selective tyrosine kinase inhibitors and everolimus in HPV-dependent SCC","volume":"vol. 40","author":"Birk","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.biopha.2023.115035_bib203","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1093\/carcin\/bgu197","article-title":"Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive cancers","volume":"vol. 35","author":"Snellenberg","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2023.115035_bib204","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1158\/1078-0432.CCR-15-0279","article-title":"Wee-1 Kinase inhibition sensitizes high-risk HPV+ HNSCC to apoptosis accompanied by downregulation of MCl-1 and XIAP antiapoptotic roteins","volume":"vol. 21","author":"Tanaka","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2023.115035_bib205","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.oraloncology.2005.05.014","article-title":"Use of fuzzy neural networks in modeling relationships of HPV infection with apoptotic and proliferation markers in potentially malignant oral lesions","volume":"vol. 41","author":"Campisi","year":"2005","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib206","doi-asserted-by":"crossref","unstructured":"E. Chrysomali, J.S. Greenspan, N. Dekker, D. Greenspan, J.A. Regezi, Apoptosis-associated proteins in oral hairy leukoplakia, Oral Dis. vol. 4 (1996) 279\u2013284. doi: 10.1111\/j.1601\u20130825. 1996.tb00238. x.","DOI":"10.1111\/j.1601-0825.1996.tb00238.x"},{"key":"10.1016\/j.biopha.2023.115035_bib207","article-title":"Overexpression of PIN1 enhances cancer growth and aggressiveness with Cyclin D1 induction in EBV-associated nasopharyngeal carcinoma","volume":"vol. 11","author":"Xu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115035_bib208","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1038\/s41598-017-03156-3","article-title":"Epstein-Barr virus-induced up-regulation of TCAB1 is involved in the DNA damage response in nasopharyngeal carcinoma","volume":"vol. 7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115035_bib209","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/(SICI)1097-0347(199908)21:5<454::AID-HED12>3.0.CO;2-O","article-title":"Epstein-Barr virus infection and P53 expression in HIV-related oral large B cell lymphoma","volume":"vol. 21","author":"Calzolari","year":"1999","journal-title":"Head. Neck"},{"key":"10.1016\/j.biopha.2023.115035_bib210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cellsig.2017.09.020","article-title":"Metformin triggers apoptosis in PEL cells and alters bortezomib-induced unfolded protein response increasing its cytotoxicity and inhibiting KSHV lytic cycle activation","volume":"vol. 40","author":"Granato","year":"2017","journal-title":"Cell. Signal"},{"key":"10.1016\/j.biopha.2023.115035_bib211","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.3892\/or.2017.5978","article-title":"In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida","volume":"vol. 38","author":"Ishikawa","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2023.115035_bib212","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13046-017-0632-z","article-title":"Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death","volume":"vol. 36","author":"Granato","year":"2017","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2023.115035_bib213","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/ijpcdr.ijpcdr_10_22","article-title":"An overview of the oral primary preventive measures at public\/community level in India","volume":"vol. 9","author":"Vaghela","year":"2022","journal-title":"Int. J. Prev. Clin. Dent. Res"},{"key":"10.1016\/j.biopha.2023.115035_bib214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2001-1326-3-3","article-title":"A review of research on salivary biomarkers for oral cancer detection","volume":"vol. 3","author":"Cheng","year":"2014","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.biopha.2023.115035_bib215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40661-017-0047-8","article-title":"Therapeutic options for treatment of human papillomavirus-associated cancers \u2013 novel immunologic vaccines: ADXS11-001","volume":"vol. 4","author":"Miles","year":"2017","journal-title":"Gynecol. Oncol. Res. Pract."},{"key":"10.1016\/j.biopha.2023.115035_bib216","doi-asserted-by":"crossref","unstructured":"M. Slingerland, F. Speetjens, M. Welters, H. Gelderblom, I. Roozen, L.A. Velden, C.J. Meleif, M. Zandvliet, S.V.D. Burg, F. Ossendorp, A phase I study in patients with a human papillomavirus type 16 positive oropharyngeal tumor treated with second generation synthetic long peptide vaccine conjugated to a defined adjuvant, J. Clinic. Oncol. vol. 34 (15_suppl) (2016) TPS3113. doi: 10.1200\/JCO.2016.34.15_suppl.TPS3113.","DOI":"10.1200\/JCO.2016.34.15_suppl.TPS3113"},{"key":"10.1016\/j.biopha.2023.115035_bib217","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","article-title":"Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial","volume":"vol. 386","author":"Trimble","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.115035_bib218","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.734471","article-title":"Epstein Barr virus: development of vaccines and immune cell therapy for EBV-associated diseases","volume":"vol. 12","author":"Cui","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115035_bib219","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1016\/j.vaccine.2019.04.071","article-title":"A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits","volume":"vol. 37","author":"Mulama","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2023.115035_bib220","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1054\/ijom.2002.0313","article-title":"The prognostic implications of the surgical margin in the oral squamous cell carcinoma","volume":"vol. 32","author":"Sutton","year":"2003","journal-title":"Int. J. Oral. Maxillofac. Surg."},{"key":"10.1016\/j.biopha.2023.115035_bib221","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.oraloncology.2008.05.017","article-title":"Current concepts in management of oral cancer - Surgery","volume":"vol. 45","author":"Shah","year":"2009","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib222","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10147-012-0513-6","article-title":"Recent advances in reconstructive surgery: head and neck reconstruction","volume":"vol. 18","author":"Sakuraba","year":"2013","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib223","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJMoa1506007","article-title":"Elective versus therapeutic neck dissection in node-negative oral cancer","volume":"vol. 373","author":"Cruz","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2023.115035_bib224","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.4317\/medoral.18772","article-title":"Oral cancer: current role of radiotherapy and chemotherapy","volume":"vol. 18","author":"Huang","year":"2013","journal-title":"Med. Oral. Patol. Oral. Cir. Bucal"},{"key":"10.1016\/j.biopha.2023.115035_bib225","doi-asserted-by":"crossref","first-page":"158","DOI":"10.20517\/2347-9264.2016.13","article-title":"The role of radiotherapy in the treatment of oral cavity cancer","volume":"vol. 3","author":"Joaquin","year":"2016","journal-title":"Plast. Aesthet. Res"},{"key":"10.1016\/j.biopha.2023.115035_bib226","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.4103\/0973-1482.92218","article-title":"The role of intensity modulated radiotherapy in advanced oral cavity carcinoma","volume":"vol. 8","author":"Bhide","year":"2012","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.biopha.2023.115035_bib227","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cncr.28372","article-title":"Improved survival using intensity-modulated radiation therapy in head and neck","volume":"vol. 120","author":"Beadle","year":"2014","journal-title":"Cancer.: a SEER-Medicare Anal., Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib228","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1200\/JCO.2003.04.171","article-title":"Does delay in starting treatment affect the outcomes of radiotherapy? a systematic review","volume":"vol. 21","author":"Huang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib229","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2009.01.005","article-title":"GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas","volume":"vol. 91","author":"Mazeron","year":"2009","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.disamonth.2020.101036","article-title":"Novel therapies in the management of oral cancer: an update","volume":"vol. 66","author":"Nandini","year":"2020","journal-title":"Dis. Mon."},{"key":"10.1016\/j.biopha.2023.115035_bib231","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brachy.2009.10.003","article-title":"Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma","volume":"vol. 9","author":"Guinot","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.biopha.2023.115035_bib232","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.oraloncology.2008.05.014","article-title":"Current concepts for the management of head and neck cancer: chemotherapy","volume":"vol. 45","author":"Specenier","year":"2009","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib233","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2016016272","article-title":"Oral squamous cell carcinoma: current treatment strategies and nanotechnology-based approaches for prevention and therapy","volume":"vol. 33","author":"Gharat","year":"2016","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.biopha.2023.115035_bib234","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1593\/neo.04169","article-title":"Chemotherapy-induced and\/ or radiation therapy-induced oral mucositis--complicating the treatment of cancer","volume":"vol. 6","author":"Naidu","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.biopha.2023.115035_bib235","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1021\/acsnano.5b03569","article-title":"Accelerating the translation of nanomaterials in biomedicine","volume":"vol. 9","author":"Mitragotri","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2023.115035_bib236","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2015.02.006","article-title":"Polymeric nanoparticles for codelivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation","volume":"vol. 203","author":"Rahimian","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2023.115035_bib237","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.7150\/thno.23856","article-title":"Applications of gold nanoparticles in virus detection","volume":"vol. 8","author":"Draz","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2023.115035_bib238","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/1556-276X-6-461","article-title":"A quantum dots and superparamagnetic nanoparticle-based method for the detection of HPV DNA","volume":"vol. 6","author":"Hong","year":"2011","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.biopha.2023.115035_bib239","article-title":"Immunization with a self-assembling nanoparticle vaccine displaying EBV gH\/gL protects humanized mice against lethal viral challenge","volume":"vol. 3","author":"Malhi","year":"2022","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.biopha.2023.115035_bib240","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.3390\/ijms20153733","article-title":"Inhibition of UCH-L1 deubiquitinating activity with two forms of LDN-57444 has anti-invasive effects in metastatic carcinoma cells","volume":"vol. 20","author":"Kobayashi","year":"2019","journal-title":"Inter. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115035_bib241","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41419-019-1624-z","article-title":"Silver nanoparticles selectively induce human oncogenic \u03b3-herpesvirus-related cancer cell death through reactivating viral lytic replication","volume":"vol. 10","author":"Wan","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.115035_bib242","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1021\/acsnano.9b06333","article-title":"Specific inhibition of viral microRNAs by carbon dots-mediated delivery of locked nucleic acids for therapy of virus-induced cancer","volume":"vol. 14","author":"Ju","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2023.115035_bib243","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1039\/c3nr33492a","article-title":"Multiplexed colorimetric detection of Kaposi's sarcoma associated herpesvirus and Bartonella DNA using gold and silver nanoparticles","volume":"vol. 5","author":"Mancuso","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2023.115035_bib244","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/A:1022271020390","article-title":"Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages","volume":"vol. 20","author":"Thiele","year":"2003","journal-title":"Pharma. Res."},{"key":"10.1016\/j.biopha.2023.115035_bib245","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.682286","article-title":"Nano and microparticles as potential oral vaccine carriers and adjuvants against infectious diseases","volume":"vol. 12","author":"Jazayeri","year":"2021","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2023.115035_bib246","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2003.12.032","article-title":"Characterization of poly (D, L,-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells","volume":"vol. 22","author":"Elamanchili","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2023.115035_bib247","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.105173","article-title":"Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: a single-arm, multicenter, phase 2 trial","volume":"vol. 115","author":"Adkins","year":"2021","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib248","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.snb.2016.08.091","article-title":"Gold nanoparticles-nodified nanomaghemite and quantum dots-based hybridization assay for detection of HPV","volume":"vol. 240","author":"Jimenez","year":"2017","journal-title":"Sens. Actuators B: Chem."},{"key":"10.1016\/j.biopha.2023.115035_bib249","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1600-0714.2009.00799.x","article-title":"Use of quantum dots to detect human papillomavirus in oral squamous cell carcinoma","volume":"vol. 38","author":"Xue","year":"2009","journal-title":"J. Oral. Pathol. Med"},{"key":"10.1016\/j.biopha.2023.115035_bib250","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ymthe.2018.07.019","article-title":"Nanoparticles based on poly (\u03b2-Amino Ester) and HPV16-targeting CRISPR\/shRNA as potential drugs for HPV16-related cervical malignancy","volume":"vol. 26","author":"Zhu","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2023.115035_bib251","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jconrel.2021.07.034","article-title":"Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles","volume":"vol. 337","author":"Kampel","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2023.115035_bib252","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3390\/pharmaceutics11110615","article-title":"Efficient delivery of therapeutic siRNA by Fe3O4 magnetic nanoparticles into oral cancer cells","volume":"vol. 11","author":"Jin","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.115035_bib253","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/JVI.74.14.6324-6332.2000","article-title":"Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells","volume":"vol. 74","author":"Molesworth","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.115035_bib254","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.7150\/thno.41228","article-title":"Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy","volume":"vol. 10","author":"Xu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2023.115035_bib255","doi-asserted-by":"crossref","first-page":"18000","DOI":"10.1038\/s41598-017-18177-1","article-title":"Broadly neutralizing ntiviral responses induced by a single-molecule HPV vaccine based on thermostable thioredoxin-L2 multiepitope nanoparticles","volume":"vol. 7","author":"Spagnoli","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115035_bib256","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110118","article-title":"Nanoformulated bioactive compounds: a potential approach for cancer therapy","volume":"vol. 366","author":"Venkidasamy","year":"2022","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.biopha.2023.115035_bib257","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.3390\/ijms20184567","article-title":"Combinatorial epigenetics impact of polyphenols and phytochemicals in cancer prevention and therapy","volume":"vol. 20","author":"Arora","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115035_bib258","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106060","article-title":"Isothiocyanates (AITC & BITC) bioactive molecules: therapeutic potential for oral cancer","volume":"vol. 133","author":"Rekha","year":"2022","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib259","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.sjbs.2020.11.030","article-title":"An in vitro study of Ocimum sanctum as a chemotherapeutic agent on oral cancer cell-line","volume":"vol. 28","author":"Luke","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.biopha.2023.115035_bib260","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.phymed.2016.09.005","article-title":"Copper supplementation amplifies the anti-tumor effect of curcumin in oral cancer cells","volume":"vol. 23","author":"Lee","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2023.115035_bib261","first-page":"1504","article-title":"Pterostilbene modulates the suppression of multidrug resistance protein 1 and triggers autophagic and apoptotic mechanisms in cisplatin-resistant human oral cancer CAR cells via AKT signaling","volume":"vol. 52","author":"Chang","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib262","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.biopha.2017.12.009","article-title":"[6]-Shogaol attenuates inflammation, cell proliferation via modulate NF-\u03baB and AP-1 oncogenic signaling in 7,12-dimethylbenz[a]anthracene induced oral carcinogenesis","volume":"vol. 98","author":"Annamalai","year":"2018","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2023.115035_bib263","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1038\/s41598-017-01960-5","article-title":"Nimbolide upregulates RECK by targeting miR-21 and HIF-1\u03b1 in cell lines and in a hamster oral carcinogenesis model","volume":"vol. 7","author":"Kowshik","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115035_bib264","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1007\/s13277-015-3793-4","article-title":"Resveratrol inhibits oral squamous cell carcinoma through induction of apoptosis and G2\/M phase cell cycle arrest","volume":"vol. 37","author":"Yu","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.biopha.2023.115035_bib265","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1007\/s12010-022-04006-3","article-title":"In silico analysis of the apoptotic and HPV inhibitory roles of some selected phytochemicals detected from the rhizomes of greater cardamom","volume":"vol. 194","author":"Nag","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.biopha.2023.115035_bib266","article-title":"Involvement of Nrf2-mediated upregulation of heme oxygenase-1 in mollugin-induced growth inhibition and apoptosis in human oral cancer cells","volume":"vol. 2013","author":"Lee","year":"2013","journal-title":"BioMed. Res. Int"},{"key":"10.1016\/j.biopha.2023.115035_bib267","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.31557\/APJCP.2021.22.8.2461","article-title":"Molecular landscape and computational screening of the natural inhibitors against HPV16 E6 oncoprotein","volume":"vol. 22","author":"Juneja","year":"2021","journal-title":"Asian Paci. J. Cancer Prev."},{"key":"10.1016\/j.biopha.2023.115035_bib268","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.3390\/molecules27113568","article-title":"Antiproliferative and pro-apoptotic effects of a phenolic-rich extract from Lycium barbarum fruits on human Papillomavirus (HPV) 16-positive head cancer cell lines","volume":"vol. 27","author":"Peraza-Labrador","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.115035_bib269","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cam4.1281","article-title":"Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line","volume":"vol. 7","author":"Qiu","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.biopha.2023.115035_bib270","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106044","article-title":"PEITC: a prospective natural metabolite in oral cancer treatment","volume":"vol. 133","author":"Krishnan","year":"2022","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.biopha.2023.115035_bib271","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ijc.25220","article-title":"Curcumin upregulates insulin-like growth factor binding protein-5 (IGFBP-5) and C\/EBPalpha during oral cancer suppression","volume":"vol. 127","author":"Chang","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2023.115035_bib272","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.7150\/ijbs.33710","article-title":"Potential mechanisms of action of curcumin for cancer prevention: Focus on cellular signaling pathways and miRNAs","volume":"vol. 15","author":"Wang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2023.115035_bib273","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1002\/mc.22692","article-title":"Chemoprevention of oral cancer is associated with inhibition of cancer stem cells","volume":"vol. 56","author":"Siddappa","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.biopha.2023.115035_bib274","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/030089168707300105","article-title":"Turmeric and curcumin as topical agents in cancer therapy","volume":"vol. 73","author":"Kuttan","year":"1987","journal-title":"Tumori"},{"key":"10.1016\/j.biopha.2023.115035_bib275","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1517\/14728222.2014.947962","article-title":"suppresses oral cancer cell invasion by inhibiting MMP-2 expression","volume":"vol. 18","author":"Lin","year":"2014","journal-title":"Expert. Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2023.115035_bib276","doi-asserted-by":"crossref","DOI":"10.1590\/1678-7757-2021-0209","article-title":"Anticancer effects of 6-shogaol via the AKT signaling pathway in oral squamous cell carcinoma","volume":"vol. 29","author":"Huang","year":"2021","journal-title":"J. Appl. Oral. Sci."},{"key":"10.1016\/j.biopha.2023.115035_bib277","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41419-018-1126-4","article-title":"Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K\/Akt\/GSK-3\u03b2 signalling pathway in oral cancer","volume":"Vol. 9","author":"Sophia","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.115035_bib278","first-page":"5402","article-title":"Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma, Clin","volume":"Vol. 17","author":"Tyagi","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2023.115035_bib279","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41368-020-0086-6","article-title":"Gap junction-mediated cell-to-cell communication in oral development and oral diseases: a concise review of research progress","volume":"vol. 12","author":"Liu","year":"2020","journal-title":"Int. J. Oral. Sci."},{"key":"10.1016\/j.biopha.2023.115035_bib280","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1093\/jn\/132.12.3754","article-title":"Lycopene inhibits proliferation and enhances gap-junction communication of KB-1 human oral tumor cells","volume":"Vol. 132","author":"Livny","year":"2002","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2023.115035_bib281","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/fsn3.999","article-title":"The potential use of bromelain as a natural oral medicine having anticarcinogenic activities","volume":"Vol. 7","author":"Lee","year":"2019","journal-title":"Food Sci. Nutr."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223008259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223008259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:56:56Z","timestamp":1777877816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223008259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":280,"alternative-id":["S0753332223008259"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115035","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic strategy for oncovirus-mediated oral cancer: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115035"}}